How have the FDA approvals of axi-cel and liso-cel affected the LBCL treatment paradigm?
Five years ago, irrespective of relapse status or primary refractoriness, the standard of care would have been salvage platinum-containing chemotherapy…
Real-World Studies Reinforce Axi-Cel and Liso-Cel as Effective LBCL Treatments
